Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience
Sponsor

Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

France 1 Rue Cabanis, 75014 Paris, France

About the sponsor

Clinical research in Alzheimer disease focuses on disease progression, cognitive decline, and the relationship between microglial activation, tau pathology, and synaptic density using positron emission tomography imaging.

  • Alzheimer disease
  • Cognitive impairment
  • Neuroinflammation
  • Synaptic loss

Research activity also includes biomarker-oriented work in early Alzheimer disease and longitudinal assessment of neurological deterioration.

About Specializations

Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience runs clinical trials in conditions such as Dementia Alzheimer's type, Depression, Subarachnoid haemorrhage, Anorexia nervosa, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

8 clinical trials

Effect of atomoxetine on learning dynamics in healthy adults: a study comparing single dose atomoxetine 40 mg with placebo

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:Atomoxetine
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Depression

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Subarachnoid haemorrhage

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:CILOSTAZOL
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Anorexia nervosa

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Donepezil Hydrochloride
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Central nervous system vasculitis

Not yet recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Azathioprine
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Psychotic disorder

Not yet recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Acetylcysteine
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Dementia Alzheimer's type

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:(4R)-1-[(3-(11C)Methylpyridin-4-Yl)Methyl]-4-(3,4,5-Trifluorophenyl)Pyrrolidin-2-One
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Dementia Alzheimer's type

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aldesleukin
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.